ProSomnus, Inc. (OSA)

NASDAQ: OSA · IEX Real-Time Price · USD
0.569
-0.047 (-7.67%)
At close: Mar 28, 2024, 4:00 PM
0.552
-0.017 (-3.08%)
After-hours: Mar 28, 2024, 5:27 PM EDT

Company Description

ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea.

The company sells its products to sleep dentists, sleep physicians, primary care providers, otolarygologists, and other integrated healthcare service providers through a direct sales force.

ProSomnus, Inc. is headquartered in Pleasanton, California.

ProSomnus, Inc.
ProSomnus logo
Country United States
Founded 2016
Industry Medical Devices
Sector Healthcare
Employees 129
CEO Leonard Liptak

Contact Details

Address:
5675 Gibraltar Dr
Pleasanton, California 94588
United States
Phone 844-537-5337
Website prosomnus.com

Stock Details

Ticker Symbol OSA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001934064
ISIN Number US50535E1082
Employer ID 88-2978216
SIC Code 3841

Key Executives

Name Position
Leonard Liptak Co-Founder, Chief Executive Officer and Director
Sung Kim Co-Founder and Chief Technology Officer
Laing F. Rikkers Co-founder and Executive Chairman
Brian B. Dow Chief Financial Officer
Dr. John E. Remmers M.D. Chief Scientist
Heather Whalen Vice President of Global Marketing Services
Dr. Shouresh Charkhandeh D.D.S. Global Scientific Committee Chair

Latest SEC Filings

Date Type Title
Mar 27, 2024 10-K Annual Report
Mar 26, 2024 8-K Current Report
Mar 22, 2024 8-K Current Report
Feb 16, 2024 8-K Current Report
Feb 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 EFFECT Notice of Effectiveness
Feb 13, 2024 EFFECT Notice of Effectiveness
Feb 13, 2024 POS AM Post-Effective amendments for registration statement
Feb 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 5, 2024 POS AM Post-Effective amendments for registration statement